No­var­tis chief says Trump visa re­stric­tions sour US hir­ing plans; Parex­el and Sanofi to de­vel­op wear­able de­vices

→  Don’t look for No­var­tis CEO Joe Jimenez to add many new jobs in the US any­time soon. In re­cent in­ter­views the phar­ma chief says that new visa re­stric­tions ad­vanced by the Trump ad­min­is­tra­tion has soured his ap­petite for any ex­pan­sion in the US. The com­pa­ny has al­ready felt the ef­fects on hir­ing for­eign na­tion­als. “This makes the coun­try a less at­trac­tive lo­ca­tion for in­vest­ment…by con­trast, Switzer­land and Eu­rope will be­come more at­trac­tive,” he said. Jimenez was one of sev­er­al in­dus­try lead­ers to meet with the pres­i­dent in Jan­u­ary about de­creas­ing drug prices and in­creas­ing jobs in the Unit­ed States.

Unlock this article instantly by becoming a free subscriber.

You’ll get access to free articles each month, plus you can customize what newsletters get delivered to your inbox each week, including breaking news.

SIGN UP LOG IN BECOME A PREMIUM SUBSCRIBER